These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 9507207

  • 1. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure.
    Liang K, Oveisi F, Vaziri ND.
    Kidney Int; 1998 Mar; 53(3):626-30. PubMed ID: 9507207
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of VLDL receptor expression in chronic experimental renal failure.
    Vaziri ND, Liang K.
    Kidney Int; 1997 Mar; 51(3):913-9. PubMed ID: 9067930
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis.
    Sato T, Liang K, Vaziri ND.
    Kidney Int; 2002 Jan; 61(1):157-62. PubMed ID: 11786096
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure.
    Vaziri ND, Liang K.
    Kidney Int; 1996 Dec; 50(6):1928-35. PubMed ID: 8943476
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
    Vaziri ND, Liang K, Parks JS.
    Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
    Yagyu H, Lutz EP, Kako Y, Marks S, Hu Y, Choi SY, Bensadoun A, Goldberg IJ.
    J Biol Chem; 2002 Mar 22; 277(12):10037-43. PubMed ID: 11790777
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Upregulation of fatty acid synthase gene expression in experimental chronic renal failure.
    Szolkiewicz M, Nieweglowski T, Korczynska J, Sucajtys E, Stelmanska E, Goyke E, Swierczynski J, Rutkowski B.
    Metabolism; 2002 Dec 22; 51(12):1605-10. PubMed ID: 12489075
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.
    Vaziri ND, Kim CH, Dang B, Zhan CD, Liang K.
    Am J Physiol Renal Physiol; 2004 Jul 22; 287(1):F90-4. PubMed ID: 15010358
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression.
    Vaziri ND, Liang K, Barton CH.
    Biochim Biophys Acta; 1999 Jan 04; 1436(3):577-84. PubMed ID: 9989287
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.